BLCO Stock Summary and Trading Ideas (Bausch & Lomb | NYSE:BLCO)

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Bausch & Lomb trades on the NYSE stock market under the symbol BLCO.

As of June 10, 2026, BLCO stock price declined to $15.54 with 54,513 million shares trading.

BLCO has a beta of 1.35, meaning it tends to be more sensitive to market movements. BLCO has a correlation of 0.34 to the broad based SPY ETF.

BLCO has a market cap of $5.54 billion. This is considered a Mid Cap stock.

Last quarter Bausch & Lomb reported $1 billion in Revenue and $.08 earnings per share. This beat revenue expectation by $31 million and exceeded earnings estimates by $.03.

In the last 3 years, BLCO traded as high as $21.95 and as low as $10.45.

The top ETF exchange traded funds that BLCO belongs to (by Net Assets): MGMT, DFAX, DFIC, GUSA, SHRT.

BLCO has outperformed the market in the last year with a price return of +29.7% while the SPY ETF gained +23.0%. However, in the short term, BLCO had mixed performance relative to the market. It has underperformed in the last 3 months, returning -9.8% vs +8.0% return in SPY. But in the last 2 weeks, BLCO shares have fared better than the market returning -1.5% compared to SPY -2.7%.

BLCO support price is $15.41 and resistance is $15.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BLCO shares will trade within this expected range on the day.